Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Morphological Parameters of the Leukocyte (PCDs) as Prognostic Markers in Community Acquired Pneumonia (CAP)

NCT04930926 is registered in ClinicalTrials.gov with Hospital Galdakao-Usansolo as lead sponsor.

NCT NCT04930926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04930926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Morphological Parameters of the Leukocyte (PCDs) as Prognostic Markers in Community Acquired Pneumonia (CAP)
Lead sponsor
Hospital Galdakao-Usansolo
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2019
Completion date
November 30, 2021
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infection, pulmonary disease